Low‐frequency Nonsynonymous Variants in FKBPL and ARPC1B Genes Are Associated with Breast Cancer Risk in Chinese Women

Wen Zhou,Yue Jiang,Meng Zhu,Dong Hang,Jiaping Chen,Jing Zhou,Juncheng Dai,Hongxia Ma,Zhibin Hu,Guangfu Jin,Jiahao Sha,Hongbing Shen

DOI: https://doi.org/10.1002/mc.22534

2016-01-01

Molecular Carcinogenesis

Abstract:Genome-wide association studies have reported more than 100 independent common loci associated with breast cancer risk. The contribution of low-frequency or rare variants to breast cancer susceptibility has not been well explored. Thus, we applied exome chip to genotype >200000 low-frequency and rare variants in 1064 breast cancer cases and 1125 cancer-free controls and subsequently validated promising associations in another 1040 breast cancer cases and 1240 controls. We identified two low-frequency nonsynonymous variants at FKBPL (rs200847762, OR=0.34, 95% CI=0.20-0.57, P=4.31x10(-5)) and ARPC1B (rs1045012, OR=0.56, 95% CI=0.43-0.74, P=4.30x10(-5)) associated with breast cancer risk. In stratification analyses, we found that the protective effect of rs200847762 was stronger in ER-positive breast cancer (OR=0.18, 95% CI=0.06-0.42) than that in ER-negative one (OR=0.59, 95% CI=0.31-1.05). Our findings indicate that low-frequency variants may also contribute to breast cancer susceptibility and genetic variants in 6p21.33 and 7q22.1 are important in breast carcinogenesis. (c) 2016 Wiley Periodicals, Inc.